Tag Archive for: Clinical trials

Shionogi Co., Ltd. and F2G Enter Strategic Collaboration to Develop and Commercialize the New Antifungal Agent Olorofim in Europe and Asia

/in

Shionogi to conduct clinical trials, subsequent registration, and commercialization of olorofim for invasive aspergillosis (IA) in Europe and Asia F2G to receive upfront payment of $100m and share development costs F2G will also be eligible for additional regulatory and commercial milestones of up to $380m, as well as double-digit royalties on net sales OSAKA, Japan, […]

Read more

ImaginAb Announces New Supply Agreement to Supply Genmab A/S with its Investigational CD8 ImmunoPET Agent

/in

Los Angeles, CA, USA, May 5th, 2022 – ImaginAb, Inc., a market leading global biotechnology company focused on developing next generation ImmunoPET imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce it has signed a new multi-year, non-exclusive supply agreement with Genmab A/S, an international biotechnology company. Read more…

Read more

ImaginAb Inc. and DongCheng Pharmaceutical Group Announce Plans for a CD8 ImmunoPET Commercial Partnership

/in

Both organizations working together to form a commercial partnership to launch ImaginAb’s CD8 ImmunoPET technology into the Greater China market Los Angeles (USA) and Yantai (China) – January 26th, 2022. ImaginAb, a market leading global biotechnology company, focused on developing next generation immuno-oncology imaging agents and therapeutic radiopharmaceuticals (RPT), is pleased to announce it is working […]

Read more

Ben Foster Backs Cure Leukaemia’s ‘We Will’ Campaign To Fund Nurses Across the UK

/in

Today, on International Nurses Day, at a time when clinical trials are being discussed on a daily basis regarding the COVID-19 crisis, Cure Leukaemia highlights how the crisis could impact blood cancer patients

Read more